the 2026 American Society of Clinical Oncology
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Cancer survivors saw major improvements in sleep and well-being with one weekly practice
Yoga is known to boost relaxation, strength and flexibility – and now a new study has found the practice could improve cancer survivors’ quality of life. A randomized trial led by the University of Rochester Medical Center found that a four-week yoga program significantly reduced insomnia, fatigue, anxiety and mood disturbances after cancer treatment. The findings were presented last week at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Removing ‘invisibility cloaks’ and safely skipping chemo: new weapons in war on cancer shared at US conference
Drug that stops cancer cells hiding and a breakthrough for pancreatic cancer among highlights from Asco conference – but there were also notes of cautionDoctors, scientists and researchers shared new research about ways to tackle cancer at the 2026 American Society of Clinical Oncology (Asco) annual meeting, the world’s largest cancer conference. The event in Chicago, attended by 40,000 health professionals, featured more than 200 sessions and 2,700 poster presentations on this year’s theme,...
Weight-loss drugs may cut breast cancer risk by up to 30%, study finds
Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study. Women who take GLP-1 medications, such as Ozempic or Mounjaro, are less likely to develop breast cancer, a new study has found. The findings, presented at the 2026 American Society of Clinical Oncology (ASCO) annual meeting, come from an analysis of more than 110,000 women aged between 45 and 80.
Removing ‘invisibility cloaks’ and safely skipping chemo: new weapons in war on cancer shared at US conference
Drug that stops cancer cells hiding and a breakthrough for pancreatic cancer among highlights from Asco conference – but there were also notes of cautionDoctors, scientists and researchers shared new research about ways to tackle cancer at the 2026 American Society of Clinical Oncology (Asco) annual meeting, the world’s largest cancer conference. The event in Chicago, attended by 40,000 health professionals, featured more than 200 sessions and 2,700 poster presentations on this year’s theme,...
The world will be 100 million cancer workers short by 2050, according to Lancet
A new report warns the world is heading towards a cancer care crisis, with cases sharply rising and the workforce failing to keep pace. The world will need nearly 100 million more cancer workers by 2050, a new study warns. The largest gaps will be among nurses and diagnostic specialists, particularly radiologists and pathologists, with Africa and Asia set to be the hardest hit.
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk Popular GLP-1 weight-loss drugs may have an unexpected bonus: a significantly lower risk of breast cancer. - Date: - June 6, 2026 - Source: - University of Pennsylvania School of Medicine - Summary: - A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.
We're picking up more shares of an out-of-favor stock with a bright future
We are buying 50 shares of Johnson & Johnson at roughly $221.43. Following the trade, Jim Cramer's Charitable Trust will own 340 shares of JNJ, increasing its weighting to 1.9% from 1.62%. We're picking up shares of J & J here and lowering our average cost basis as healthcare and drug stocks move lower on Monday.